Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-03-15

FDA Approved: VALSARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved the original ANDA for a generic fixed-dose combination of valsartan and hydrochlorothiazide manufactured by Zydus Lifesciences Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Valsartan and Hydrochlorothiazide (Valsartan and Hydrochlorothiazide)

Snippet

ORIG AP for VALSARTAN AND HYDROCHLOROTHIAZIDE (VALSARTAN AND HYDROCHLOROTHIAZIDE)